Abstract
Increases in extracellular calcium concentration ([Ca(2+)](o)) stimulate from normal and malignant cells secretion of parathroid hormone-related protein (PTHrP), a major mediator of humoral hypercalcemia of malignancy. Because the calcium-sensing receptor (CaR) is a determinant of calcium-regulated hormone secretion, we examined whether HEK cells stably transfected with human CaR secreted PTHrP in response to CaR stimulation. Increases in [Ca(2+)](o) or neomycin and Gd(3+) all substantially increased PTHrP secretion in CaR-HEK cells but had no effect on nontransfected cells. CaR activation likewise increased PTHrP transcripts. PD-098059 and U-0126, inhibitors of the mitogen-activated protein kinase kinase MEK1/2, abolished CaR-stimulated secretion but had no effect on basal secretion. An inhibitor of p38 MAP kinase, SB-203580, also attenuated CaR-stimulated secretion. Western analysis revealed that CaR activation caused a robust increase in MEK1/2 and p38 MAP kinase phosphorylation. A Src family kinase inhibitor, PP2, blocked both basal and CaR-stimulated secretion. We conclude that CaR specifically mediates the effect of increasing [Ca(2+)](o) on PTHrP synthesis and secretion and that activated MEK1/2 and p38 MAP kinases are determinants of the CaR's stimulation of PTHrP secretion.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adenosine Diphosphate / pharmacology
-
Aniline Compounds / pharmacology
-
Anisomycin / pharmacology
-
Calcium / agonists
-
Calcium / pharmacology
-
Cations / pharmacology
-
Cell Line
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Kidney / cytology
-
MAP Kinase Kinase 1
-
MAP Kinase Kinase 2
-
Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase Kinases / metabolism
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinases / metabolism*
-
Parathyroid Hormone-Related Protein
-
Peptide Hormones / genetics
-
Peptide Hormones / metabolism*
-
Phosphorylation
-
Protein Kinase C / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / metabolism
-
Protein Synthesis Inhibitors / pharmacology
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / metabolism
-
Receptors, Calcium-Sensing
-
Receptors, Cell Surface / genetics
-
Receptors, Cell Surface / metabolism*
-
Transcription, Genetic / drug effects
-
Transfection
-
p38 Mitogen-Activated Protein Kinases
-
src-Family Kinases / antagonists & inhibitors
Substances
-
Aniline Compounds
-
Cations
-
Enzyme Inhibitors
-
NPS R-467
-
PTHLH protein, human
-
Parathyroid Hormone-Related Protein
-
Peptide Hormones
-
Protein Synthesis Inhibitors
-
Receptors, Calcium-Sensing
-
Receptors, Cell Surface
-
Adenosine Diphosphate
-
Anisomycin
-
MAP2K2 protein, human
-
Protein-Tyrosine Kinases
-
src-Family Kinases
-
Protein Serine-Threonine Kinases
-
Protein Kinase C
-
Mitogen-Activated Protein Kinases
-
p38 Mitogen-Activated Protein Kinases
-
MAP Kinase Kinase 1
-
MAP Kinase Kinase 2
-
MAP2K1 protein, human
-
Mitogen-Activated Protein Kinase Kinases
-
Calcium